Key result
Urban exposome factors like pollution and built environment significantly drive cardiometabolic disease risk.
Why the study?
Urban environments substantially contribute to the rising burden of cardiometabolic diseases worldwide, but critical knowledge gaps remain regarding built-environment feature thresholds for optimizing cardiometabolic health outcomes.
Urban planning and built-environment interventions present a crucial opportunity to simultaneously tackle the global epidemics of cardiometabolic disease and climate change.
Urban design may shape cardiometabolic risk; leaves open prospective trials of integrated planning for health-climate co-benefits.
Urban environments contribute substantially to the rising burden of cardiometabolic diseases worldwide. Cities are complex adaptive systems that continually exchange resources, shaping exposures relevant to human health such as air pollution, noise, and chemical exposures. In addition, urban infrastructure and provisioning systems influence multiple domains of health risk, including behaviors, psychological stress, pollution, and nutrition through various pathways (eg, physical inactivity, air pollution, noise, heat stress, food systems, the availability of green space, and contaminant exposures). Beyond cardiometabolic health, city design may also affect climate change through energy and material consumption that share many of the same drivers with cardiometabolic diseases. Integrated spatial planning focusing on developing sustainable compact cities could simultaneously create heart-healthy and environmentally healthy city designs. This article reviews current evidence on the associations between the urban exposome (totality of exposures a person experiences, including environmental, occupational, lifestyle, social, and psychological factors) and cardiometabolic diseases within a systems science framework, and examines urban planning principles (eg, connectivity, density, diversity of land use, destination accessibility, and distance to transit). We highlight critical knowledge gaps regarding built-environment feature thresholds for optimizing cardiometabolic health outcomes. Last, we discuss emerging models and metrics to align urban development with the dual goals of mitigating cardiometabolic diseases while reducing climate change through cross-sector collaboration, governance, and community engagement. This review demonstrates that cities represent crucial settings for implementing policies and interventions to simultaneously tackle the global epidemics of cardiovascular disease and climate change.
No takes yet. Share an insight, caveat, or question.
Rajagopalan et al. (2024) conducted a review in Cardiometabolic diseases. Urban exposome and built environment was evaluated. The urban exposome, including pollution and built-environment infrastructure, significantly impacts cardiometabolic diseases, highlighting the need for integrated spatial planning to improve health.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: